HIV Prevention and Treatment Trials in Uganda through Johns Hopkins Clinical Trial Unit
Official title: The Johns Hopkins University - Uganda Clinical Trials Unit
Funded at Johns Hopkins University · NIH-11603151 · Data updated 2026-11-12
This grant supports Johns Hopkins' Uganda Clinical Trial Unit to run HIV prevention and treatment studies across Uganda, aiming to help end the global HIV pandemic.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project start | February 5, 2007 |
| Project end | November 30, 2027 |
| Funding year | 2026 |
| Award (this year) | $123,027 |
| NIH project number | 3UM1AI069530-20S4 |
| Project ID | NIH-11603151 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults at risk for HIV or living with HIV in Uganda, including pregnant women and other high-risk groups, who meet protocol-specific criteria.
✕Less likely to help
Some participants may not directly benefit if assigned to control groups or if a trial is not available at a given time.
What this research studies
If you are living with HIV or at risk in Uganda, this program helps run advanced clinical trials at multiple sites to test new prevention methods, therapies, and vaccines. The unit has a long history of PMTCT and adult HIV research and plans to expand with new networks and sites to reach more diverse populations. By joining with national and international networks, this project seeks to accelerate finding better vaccines and treatments in real-world settings. Participation could involve being part of trials for maternal and pediatric HIV care, or adult therapeutics and prevention studies, depending on the site and protocol availability.
Why it matters
Potential benefit: Could lead to better HIV prevention, vaccines, and treatments that improve health and reduce transmission for people in Uganda and similar settings.
How similar studies have gone: Previous HIV prevention and treatment trials conducted by the unit have contributed to significant advances in PMTCT and adult HIV care.
Where this research is happening
-
Johns Hopkins University
Baltimore, United States Active
Researchers
- Principal investigator: Fowler, Mary Glenn — Johns Hopkins University
- Study coordinator: Fowler, Mary Glenn
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.